Last $355.61 USD
Change Today -4.91 / -1.36%
Volume 669.4K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alfred G. Gilman M.D., Ph.D.

Co-Founder, Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
72$1,418,763

Background*

Dr. Alfred G. Gilman, M.D., Ph.D. is the Co-Founder of Regeneron Pharmaceuticals, Inc. Dr. Gilman has been Raymond and Ellen Willie Professor of Molecular Neuropharmacology and Chairman of the Department of Pharmacology at The University of Texas Southwestern Medical Center at Dallas since 1981. He serves as an Executive Vice President for Academic Affairs and Provost, The University of Texas Southwestern Medical Center at Dallas. He has been the Dean of the University ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: --

Board Members Memberships*

1990-Present
Co-Founder, Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee
1995-N/A
Former Director

Education*

Honors Degree 1990
The University of Chicago
BS 1962
Yale University
Honors Degree 1997
Yale University
PhD 1969
Case Western Reserve University
MD 1969
Case Western Reserve University
Honors Degree 1995
Case Western Reserve University
Honors Degree 1999
University of Miami

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,000
Total Calculated Compensation$1,418,763
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $355.61 USD -4.91

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB SA
€2.1M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.